ConductScience.org, home

Paper41359628

The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination.

Wang L and 4 others. PLoS Biol, 2025. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination. Papers, record 41359628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41359628

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination.
PubMed
Journal
PLoS Biol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-03
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang LLongqiang
2Wu XXiao
3Paul AAtanu
4Yao JJun
5Wang BBinhttps://orcid.org/0000-0003-3352-6992

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ubiquitin-Conjugating EnzymesMajor topic
BRCA1 ProteinMajor topic
Deubiquitinating EnzymesMajor topic
Anaphase-Promoting Complex-CyclosomeMajor topic
Ubiquitination
Humans
Female
Breast Neoplasms
Lysine
Protein Stability
Cell Line, Tumor
HEK293 Cells
Cadherins

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA248088NCI NIH HHSUnited StatesR01CA248088PubMed

Source NIH RePORTER

Download CSV of grants

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117525340Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response.Science2007https://conductscience.org/library/papers/17525340PubMed
215829966Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.Nature2005https://conductscience.org/library/papers/15829966PubMed
319261749NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control.Genes Dev2009https://conductscience.org/library/papers/19261749PubMed
427732584Molecular basis of Lys11-polyubiquitin specificity in the deubiquitinase Cezanne.Nature2016https://conductscience.org/library/papers/27732584PubMed
534527184Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer.Comput Struct Biotechnol J2021https://conductscience.org/library/papers/34527184PubMed
637578980DNA repair function scores for 2172 variants in the BRCA1 amino-terminus.PLoS Genet2023https://conductscience.org/library/papers/37578980PubMed
711278247The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.J Biol Chem2001https://conductscience.org/library/papers/11278247PubMed
830760478PARP Inhibitors: Extending Benefit Beyond BRCA-Mutant Cancers.Clin Cancer Res2019https://conductscience.org/library/papers/30760478PubMed
924002223Push back to respond better: regulatory inhibition of the DNA double-strand break response.Nat Rev Mol Cell Biol2013https://conductscience.org/library/papers/24002223PubMed
1019820702UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit.Nat Cell Biol2009https://conductscience.org/library/papers/19820702PubMed
1122460905The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2012https://conductscience.org/library/papers/22460905PubMed
1228302823PARP inhibitors: Synthetic lethality in the clinic.Science2017https://conductscience.org/library/papers/28302823PubMed
1324472556HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.Biochem Biophys Res Commun2014https://conductscience.org/library/papers/24472556PubMed
1415166217Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression.J Biol Chem2004https://conductscience.org/library/papers/15166217PubMed
158576261Novel multiubiquitin chain linkages catalyzed by the conjugating enzymes E2EPF and RAD6 are recognized by 26 S proteasome subunit 5.J Biol Chem1996https://conductscience.org/library/papers/8576261PubMed
1623086937The F-box protein FBXO44 mediates BRCA1 ubiquitination and degradation.J Biol Chem2012https://conductscience.org/library/papers/23086937PubMed
1724142877Physiological modulation of endogenous BRCA1 p220 abundance suppresses DNA damage during the cell cycle.Genes Dev2013https://conductscience.org/library/papers/24142877PubMed
1826778126Structure of BRCA1-BRCT/Abraxas Complex Reveals Phosphorylation-Dependent BRCT Dimerization at DNA Damage Sites.Mol Cell2016https://conductscience.org/library/papers/26778126PubMed
191846030Cyclin is degraded by the ubiquitin pathway.Nature1991https://conductscience.org/library/papers/1846030PubMed
208780884BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.Cell Growth Differ1996https://conductscience.org/library/papers/8780884PubMed

See all 67 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42942146Beyond Homologous Recombination: Functional Modules of Olaparib Resistance Revealed by CRISPR Screens.Int J Mol Sci2026https://conductscience.org/library/papers/42942146

Source PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
OTUD7B56957PubTator's text mininghttps://conductscience.org/library/genes/56957NCBI Gene
UBE2S27338PubTator's text mininghttps://conductscience.org/library/genes/27338NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41359628

GET https://conductscience.org/api/papers/v1/41359628/references?page=2